Aprea Therapeutics
Price & Volume
Stats
See more52W Range | $0.84-$4.65 |
Market Cap | $6.2M |
Shares Short | 34,578 |
Financials
See moreRevenue (12 Mos) | $488,239 |
Revenue Growth (YoY) | -99.5% |
Gross Profit (12 Mos) | -$7.9M |
Diluted EPS | -$2.12 |
News
See moreYahoo Finance • 23 days ago
Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026
Yahoo Finance • 2 months ago
Aprea Therapeutics GAAP EPS of -$0.47, revenue of $1.84M
Yahoo Finance • 3 months ago
Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051
Yahoo Finance • 4 months ago
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
About
CEO | Dr. Oren Gilad Ph.D. |
CFO | Mr. John P. Hamill CPA |
Address | 3805 Old Easton Road, Doylestown, PA, United States, 18902 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
